Most patients "minimally improved". This is a weak result.
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Angelman
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.10%
!
$14.62

Most patients "minimally improved". This is a weak result.
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.62 |
Change
0.440(3.10%) |
Mkt cap ! $1.815B |
Open | High | Low | Value | Volume |
$14.36 | $14.75 | $14.36 | $3.123M | 214.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 627 | $14.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.62 | 199 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 142 | 14.610 |
3 | 70 | 14.600 |
6 | 597 | 14.590 |
8 | 677 | 14.580 |
8 | 1443 | 14.570 |
Price($) | Vol. | No. |
---|---|---|
14.620 | 157 | 4 |
14.630 | 928 | 7 |
14.640 | 1914 | 8 |
14.650 | 6300 | 7 |
14.660 | 1306 | 5 |
Last trade - 11.00am 10/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |